Advertiser / Brand
Kenvue vs P&G
Structured technology and market comparison · 2026
Direct Feature Comparison
Kenvue · vs · P&GPublic consumer health brand owner spun out from Johnson & Johnson.
Global consumer goods company selling household and personal care brands.
Analyze all overlapping signals and tech stacks for Kenvue and P&G
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Kenvue and P&G?
When comparing Kenvue and P&G, both platforms operate within the Advertiser / Brand ecosystem. Kenvue is positioned as Public consumer health brand owner spun out from Johnson & Johnson, whereas P&G focuses on Global consumer goods company selling household and personal care brands. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Kenvue and P&G?
When evaluating Kenvue and P&G, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Kenvue and P&G compare?
Kenvue is headquartered in United States (founded in 2023) with >5,000 employees. P&G is based in United States (founded in 1837) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Kenvue vs P&G
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Kenvue
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kenvue (2026-11-04)
On November 4, 2026, Kenvue LLC (as successor in interest to Kenvue Inc.) announced the settlement of exchange offers and consent solicitations conducted by Kimberly-Clark Corporation. Kimberly-Clark exchanged up to $7.0 billion aggregate principal amount of newly issued notes and cash for outstanding Kenvue senior notes across seven series maturing between 2028 and 2063. In total, approximately $6.38 billion aggregate principal amount of Kenvue Notes were validly tendered, accepted, and retired, leaving approximately $624.0 million outstanding across the seven series. Concurrent with the exchange, the Kenvue Third Supplemental Indenture became operative, substantially eliminating restrictive covenants, certain events of default, SEC reporting obligations, and merger/asset transfer restrictions under the Kenvue Indenture. Additionally, following an NYSE Form 25-NSE filing on November 2, 2026, Kenvue's common stock will be formally delisted on November 12, 2026, marking the post-acquisition integration of Kenvue under Kimberly-Clark.
- Kimberly-Clark accepted and cancelled $6,376,039,000 aggregate principal amount of Kenvue Notes across seven tranches, leaving $623,961,000 outstanding.
- The Third Supplemental Indenture stripped the Kenvue Indenture of substantially all restrictive covenants, SEC reporting requirements, and merger/asset transfer limits.
- Following an NYSE Form 25-NSE filing on November 2, 2026, Kenvue's Common Stock will be delisted from the New York Stock Exchange effective November 12, 2026.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kenvue (2026-11-02)
On November 2, 2026, Kenvue Inc. completed its merger with Kimberly-Clark Corporation (K-C), becoming a direct, wholly owned subsidiary named Kenvue LLC. Under the terms of the merger agreement, each share of Kenvue common stock was converted into the right to receive 0.14625 shares of K-C common stock plus $3.50 in cash. In connection with the closing, Kenvue terminated its $4.0 billion revolving credit agreement with JPMorgan Chase Bank, N.A., under which no borrowings were outstanding. Kenvue's entire 12-member board of directors resigned, and common stock was requested to be delisted from the New York Stock Exchange. Additionally, Kenvue LLC entered into a Fourth Supplemental Indenture assuming all obligations under seven tranches of outstanding senior notes aggregating $7.0 billion.
- Kenvue common stock converted into 0.14625 shares of Kimberly-Clark common stock plus $3.50 in cash per share, resulting in the delisting of KVUE from the NYSE.
- Kenvue terminated its $4.0 billion senior unsecured revolving credit facility with JPMorgan Chase Bank, N.A., having zero borrowings outstanding at closing.
- Kenvue LLC formally assumed obligations on $7.0 billion in total aggregate principal across seven series of outstanding senior notes due between 2028 and 2063.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kenvue (2026-10-30)
Kenvue Inc. filed a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition) on October 30, 2026, announcing its financial results for the fiscal third quarter ended September 27, 2026. The full quarterly financial release was furnished as Exhibit 99.1. The filing serves as the formal SEC disclosure vehicle for the company's third-quarter earnings release, signed by Interim Chief Financial Officer and Chief Accounting Officer Heather Howlett.
- Kenvue furnished its fiscal third-quarter financial results for the period ended September 27, 2026 via Exhibit 99.1 on October 30, 2026.
- The filing is furnished pursuant to Item 2.02 and is not deemed filed under Section 18 of the Securities Exchange Act of 1934.
- The Form 8-K was executed by Heather Howlett in her capacity as Interim Chief Financial Officer and Chief Accounting Officer.
P&G
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for P&G (2026-10-30)
On October 30, 2026, The Procter & Gamble Company closed a multi-tranche underwritten public debt offering totaling $4.0 billion in aggregate principal amount under its Form S-3 shelf registration. The issuance comprises four tranches: $750 million of 5.125% Notes due 2031, $750 million of 5.300% Notes due 2033, $1.25 billion of 5.450% Notes due 2036, and $1.25 billion of 5.900% Notes due 2056. The large-scale capital raise locks in medium- and long-term liquidity across 5-year, 7-year, 10-year, and 30-year maturities. This debt financing provides P&G with substantial balance sheet flexibility to support general corporate purposes, debt refinancing, and operational capital allocation requirements.
- P&G closed an underwritten public offering of $4.0 billion in total aggregate principal across four tranches on October 30, 2026.
- The offering includes $750M of 5.125% Notes due 2031, $750M of 5.300% Notes due 2033, $1.25B of 5.450% Notes due 2036, and $1.25B of 5.900% Notes due 2056.
- The debt was issued under P&G's Form S-3 registration statement (Registration No. 333-299472) with legal opinions filed by internal counsel and Fried, Frank, Harris, Shriver & Jacobson LLP.
- ·SEC APIfinancials
10-Q Financial Filing Analysis for P&G (2026-10-22)
For the first fiscal quarter ended September 30, 2026, The Procter & Gamble Company reported consolidated net sales of $23.28 billion, up 4.0% year-over-year, driven by a 2.4% unit volume increase, 1.1% positive geographic mix, and 0.4% higher pricing. Operating income rose 1.4% to $5.94 billion, while gross margin contracted 160 basis points to 49.8% due to higher commodity costs and product/packaging investments, partially offset by manufacturing productivity gains. Net earnings attributable to P&G declined marginally to $4.73 billion, while diluted EPS increased 1% to $1.97 (Core EPS rose 1% to $2.00). Operating cash flow reached $5.77 billion with free cash flow of $4.40 billion, demonstrating solid 93% free cash flow productivity. Subsequent to quarter-end on October 1, 2026, P&G completed the $3.9 billion all-cash acquisition of premium wellness brand Thorne. The company also progressed its two-year $2.0 billion portfolio and productivity restructuring plan, which aims to reduce up to 7,000 non-manufacturing personnel by the end of fiscal 2027.
- Net sales rose 4.0% year-over-year to $23.28 billion, supported by 2.4% volume growth and 4.0% organic sales growth.
- Gross margin compressed by 160 basis points to 49.8%, impacted by commodity headwinds and packaging investments, though buffered by SG&A leverage to deliver $5.94 billion in operating income.
- Closed the $3.9 billion all-cash acquisition of wellness supplement maker Thorne on October 1, 2026, integrating it into Personal Health Care.
- ·SEC APIfinancials
8-K Financial Filing Analysis for P&G (2026-10-16)
The Procter & Gamble Company filed a Form 8-K reporting the final voting results from its Annual Meeting of Shareholders held on October 13, 2026. Shareholders approved all management-sponsored proposals, including the election of 12 directors for one-year terms, the ratification of the independent registered public accounting firm, and the advisory approval of executive compensation ('Say on Pay'). Conversely, all three shareholder-sponsored proposals—addressing lower thresholds for special meetings, eligibility thresholds for shareholder proposal proponents, and annual reporting on charitable contributions—were defeated by substantial margins.
- All 12 director nominees, including Ashley McEvoy (1.64B votes for) and Joseph Jimenez (1.56B votes for), were elected to one-year terms on the Board.
- Executive compensation ('Say on Pay') was approved with 1,514,086,600 votes in favor, 138,017,439 against, and 13,038,485 abstentions.
- Three shareholder proposals were rejected, including a measure to lower the special meeting threshold (608.5M votes for vs. 1.04B against) and a charitable contribution disclosure proposal (defeated with 1.57B votes against).
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Kenvue and P&G share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks